Seeking Alpha

William Haynes

 
ABOUT
Academic, physician, technology orientated amateur investor.
SNAPSHOT
  • Description: Professor. Trading frequency: Monthly
  • Interests: Bonds, Dividend stock ideas & income, ETFs, Mutual funds, Stocks - long, Tech stocks
COMPANY
Currently, you have no company profile. Click edit to add a company profile.
BLOG
Currently, you have no blog details. Click edit to add blog details.
Book
Currently, you have no book details. Click edit to add book details.
LATEST STOCKTALK more »
FDA panel vote on proven unsafe drug Meridia (ABT) was split 8:8. This panel may be more sympathetic to lorcaserin (ARNA) than anticipated. Sep 15, 2010